| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.23B | +5.1% |
| Cost of Revenue | $1.68B | +6.8% |
| R&D Expense | $9.5M | -13.8% |
| SG&A Expense | $234.3M | +1.7% |
| Operating Income | $348.6M | +0.8% |
| Interest Expense | $36.4M | +1.8% |
| Pre-tax Income | $314.4M | -20.6% |
| Income Tax | $75.8M | -15.3% |
| Net Income | $238.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.2M | +4.0% |
| Short-term Investments | $3.8M | -0.2% |
| Accounts Receivable | $60.8M | -14.0% |
| Inventory | $22.9M | +40.5% |
| Current Assets | $771.6M | -0.3% |
| Total Assets | $2.62B | +4.7% |
| Current Liabilities | $367.9M | -20.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $244.7M | -36.6% |
| Capital Expenditures | $198.3M | -36.2% |
| Investing Cash Flow | -$256.2M | +15.9% |
| Financing Cash Flow | $14.0M | +115.5% |
| Free Cash Flow | $46.4M | -38.1% |
| -22.1% |
| EPS (Basic) | $2.60 | -19.8% |
| EPS (Diluted) | $2.60 | -19.8% |
| Long-term Debt |
| $1.28B |
| +7.8% |
| Stockholders' Equity | $748.3M | +17.4% |